arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PFIZER INC

PFE
$28.15 ▲ +0.22 (+0.79%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
75 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

PFIZER INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $160.4B
Dividend Yield 3.06%
Revenue Growth 2.6%
Op. Margin
ROIC
FCF / Share $0.05
Trailing P/E
Price / Book 1.9x
FCF Yield 0.2%
Debt / Equity 0.71
info Valuation on last close. End-of-day price, Sep 23, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$15.03B
↑ +2.6%
Net Income Profit after all expenses
$-248.00M
↓ -109.2%
FCF / Share Free cash flow per share
$0.05
↓ -86.2%
Long-Term Debt Long-term obligations
$60.49B
— -0.1%

Health Breakdown

Profitability
70
Returns
64
Financial Health
39
Cash Quality
72

Dividend History

Dividend / share · sourced from SEC filings
$1.72 Latest / share
+1.8% YoY
+4.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 75 quarters